SIRT1 and Parkinson disease: Treatment with epigallocatechin gallate [61], quercetin [73], resveratrol [113] or fucoidan [123], sesamol/sesamin [128], astragaloside IV [78], panaxatriol saponin [84], or salidroside [144] in PD models activates sirtuin 1 (SIRT1) signaling, which promotes PGC1α signaling and Forkhead box O3 signaling, which are involved in the biogenesis/bioenergetics and mitophagy/redox of mitochondria, respectively [149].